Pharmaron Beijing: Announcement regarding redemption of $300 million zero-coupon convertible bonds due in 2026 and withdrawal of their listing status.
Pharmaron Beijing: Announcement regarding the redemption of $300 million zero-coupon convertible bonds due in 2026.
Pharmaron Beijing: Announcement regarding the redemption of RMB 1916 million zero-coupon USD settlement convertible bonds due in 2026 and the withdrawal of its listing status.
Pharmaron Beijing: Announcement of Resolutions for the 2023 Annual Shareholders' Meeting, the 2024 First Category A-Share Shareholders' Meeting, and the 2024 First Category H-Share Shareholders' Meeting.
Pharmaron Beijing: Legal Opinion of Zhong Lun Law Firm on the Annual General Meeting of Shareholders of the Company in 2023, the First Class A Shareholders' Meeting in 2024, and the First Class H Shareholders' Meeting in 2024.
Pharmaron Beijing: Prompt announcement on holding the 2023 Annual General Meeting of Shareholders, the 2024 First Class A Share Shareholders' Meeting, and the 2024 First Class H Shareholders' Meeting
Pharmaron Beijing: Announcement on the progress of participation in private equity investment funds and related transactions
Pharmaron Beijing: Notice on convening the 2023 Annual General Meeting of Shareholders, the 2024 First Class A Share Shareholders' Meeting, and the 2024 First Class H Shareholders' Meeting
Kanglong Chemical: Announcement on the deferral of repurchase of shares pledged by the actual controller of the company
Kanglong Chemical: Announcement on progress in participating in private equity investment funds and related transactions
Kanglong Chemical: Announcement on the deferral of repurchase of shares pledged by the actual controller of the company
Kanglong Chemical: Special instructions of the board of directors on the company's 2023 hedging product transactions
Kanglong Chemical: “Cumulative Voting System Implementation Rules” (March 2024)
Kanglong Chemical: 2023 Independent Non-Executive Director Debriefing Report (Zhou Qilin)
Kanglong Chemical: “Working System for Independent Non-Executive Directors” (March 2024)
Kanglong Chemical: “Rules of Work for the Audit Committee of the Board of Directors” (March 2024)
Kanglong Chemical: Announcement on increasing registered capital and amending the “Articles of Association”
Kanglong Chemical: Announcement on Using Some Idle Own Funds to Purchase Wealth Management Products
Kang Long Chemical: 2023 Independent Non-Executive Director Debriefing Report (Zeng Kunhong)
Kanglong Chemical: “Foreign Investment Management System” (March 2024)
No Data